• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

致聋药物、耳鸣药物、头晕和眩晕药物:更新版指南。

Drugs inducing hearing loss, tinnitus, dizziness and vertigo: an updated guide.

机构信息

Department of Sense Organs, Sapienza University of Rome, Rome, Italy.

出版信息

Eur Rev Med Pharmacol Sci. 2020 Aug;24(15):7946-7952. doi: 10.26355/eurrev_202008_22477.

DOI:10.26355/eurrev_202008_22477
PMID:32767320
Abstract

OBJECTIVE

The awareness of audio-vestibular side effects of drugs, such as hearing loss, tinnitus, dizziness and vertigo, has widely increased in the recent years. The present guide represents an update of the previous documents published by the authors in 2005 and 2011 on drug-induced ototoxicity and vestibulotoxicity.

MATERIALS AND METHODS

The authors performed a comprehensive analysis of audio-vestibular side effects of commercially available drugs based on the British National Formulary, a pharmaceutical reference book that contains a wide range of useful information and advice on prescription and pharmacology.

RESULTS

Commercially available drugs and their active principles have been classified based on their audio-vestibular side effects, as reported by the pharmaceutical companies and/or health agencies. Drugs have been categorized based on the field of application, the therapeutic indication and the pharmacological properties.

CONCLUSIONS

General practitioners, otolaryngology, neurology and audiology specialists should be aware of possible audio-vestibular side effects of drugs, such as hearing loss, tinnitus, dizziness and vertigo. The present guide represents a practical tool to rapidly identify potential audio-vestibular side effects of drugs as reported by the pharmaceutical companies and/or health agencies.

摘要

目的

近年来,人们对药物的耳毒性和前庭毒性等听觉-平衡副作用的认识有了显著提高,例如听力损失、耳鸣、头晕和眩晕。本指南是作者在 2005 年和 2011 年发表的关于药物性耳毒性和前庭毒性的先前文件的更新。

材料和方法

作者根据英国国家处方集(British National Formulary)对市售药物的听觉-平衡副作用进行了全面分析,这是一本医药参考书,包含了处方和药理学方面的广泛有用信息和建议。

结果

根据制药公司和/或卫生机构的报告,市售药物及其活性成分已根据其听觉-平衡副作用进行了分类。药物根据应用领域、治疗适应证和药理学特性进行分类。

结论

全科医生、耳鼻喉科医生、神经科医生和听力学专家应该意识到药物可能引起的听觉-平衡副作用,如听力损失、耳鸣、头晕和眩晕。本指南是一个实用工具,可以快速识别制药公司和/或卫生机构报告的潜在药物听觉-平衡副作用。

相似文献

1
Drugs inducing hearing loss, tinnitus, dizziness and vertigo: an updated guide.致聋药物、耳鸣药物、头晕和眩晕药物:更新版指南。
Eur Rev Med Pharmacol Sci. 2020 Aug;24(15):7946-7952. doi: 10.26355/eurrev_202008_22477.
2
Pharmacological drugs inducing ototoxicity, vestibular symptoms and tinnitus: a reasoned and updated guide.致聋性、前庭症状和耳鸣的药物诱导作用:合理且最新的指南。
Eur Rev Med Pharmacol Sci. 2011 Jun;15(6):601-36.
3
Audiological and vestibular symptoms following SARS-CoV-2 infection and COVID-19 vaccination in children aged 5-11 years.儿童 5-11 岁人群感染 SARS-CoV-2 后和接种 COVID-19 疫苗后的听觉和前庭症状。
Am J Otolaryngol. 2023 Jan-Feb;44(1):103669. doi: 10.1016/j.amjoto.2022.103669. Epub 2022 Oct 20.
4
Dizziness and vertigo in an older population: the Blue Mountains prospective cross-sectional study.老年人头晕和眩晕:蓝山前瞻性横断面研究。
Clin Otolaryngol. 2009 Dec;34(6):552-6. doi: 10.1111/j.1749-4486.2009.02025.x.
5
[An updated guide on drugs inducing ototoxicity, tinnitus and vertigo].[关于引起耳毒性、耳鸣和眩晕的药物的最新指南]
Acta Otorhinolaryngol Ital. 2005 Oct;25(5 Suppl 81):3-31.
6
Is COVID-19 associated with self-reported audio-vestibular symptoms?新冠病毒(COVID-19)是否与自我报告的听觉-前庭症状相关?
Int J Audiol. 2022 Oct;61(10):832-840. doi: 10.1080/14992027.2021.1957161. Epub 2021 Aug 9.
7
Hearing Loss, Tinnitus, and Dizziness in COVID-19: A Systematic Review and Meta-Analysis.新型冠状病毒肺炎相关听力损失、耳鸣和头晕:系统评价和荟萃分析。
Can J Neurol Sci. 2022 Mar;49(2):184-195. doi: 10.1017/cjn.2021.63. Epub 2021 Apr 12.
8
Drug-induced diseases in otolaryngology - causes, clinical signs, treatment.耳鼻咽喉科药物性疾病——病因、临床特征、治疗。
Otolaryngol Pol. 2021 Feb 16;75(5):9-15. doi: 10.5604/01.3001.0014.7445.
9
Audio-vestibular signs and symptoms in Chiari malformation type i. Case series and literature review.I型Chiari畸形的听觉前庭症状和体征。病例系列及文献综述。
Acta Otorrinolaringol Esp. 2015 Jan-Feb;66(1):28-35. doi: 10.1016/j.otorri.2014.05.002. Epub 2014 Sep 4.
10
Can Type of Dizziness Influence the Vestibular Caloric Test Result?头晕类型是否会影响前庭冷热试验结果?
J Prim Care Community Health. 2021 Jan-Dec;12:21501327211030120. doi: 10.1177/21501327211030120.

引用本文的文献

1
Tinnitus Stepped-Care: A Model for Standardizing Clinical Services for Tinnitus.耳鸣阶梯式护理:一种规范耳鸣临床服务的模式。
Semin Hear. 2025 Mar 7;45(3-04):255-275. doi: 10.1055/s-0045-1804509. eCollection 2024 Aug.
2
Enhanced response and safety of combining dunhuang 'moxibustion classic' acupuncture with carbamazepine in treating neuropathic tinnitus and identifying risk factors affecting sleep quality.《敦煌“灸经”针刺联合卡马西平治疗神经性耳鸣的疗效及安全性增强并识别影响睡眠质量的危险因素》
Am J Transl Res. 2024 Nov 15;16(11):6435-6446. doi: 10.62347/CQIR3328. eCollection 2024.
3
Drug-induced hearing disorders: a disproportionality analysis of the FAERS database.
药物性听力障碍:对FDA不良事件报告系统(FAERS)数据库的不成比例性分析
Front Pharmacol. 2024 Nov 22;15:1480994. doi: 10.3389/fphar.2024.1480994. eCollection 2024.
4
Tinnitus prevalence and associated risk factors among university students: A cross-sectional study.大学生耳鸣患病率及相关危险因素:一项横断面研究。
SAGE Open Med. 2024 Sep 25;12:20503121241283344. doi: 10.1177/20503121241283344. eCollection 2024.
5
Exploring delivery systems for targeted nanotechnology-based gene therapy in the inner ear.探索内耳中基于靶向纳米技术的基因治疗的递药系统。
Ther Deliv. 2024;15(10):801-818. doi: 10.1080/20415990.2024.2389032. Epub 2024 Sep 26.
6
Awareness and Attitude About Ototoxic Drugs Among Medical Doctors in Arar City, Saudi Arabia.沙特阿拉伯阿拉尔市医生对耳毒性药物的认知与态度
Cureus. 2024 May 16;16(5):e60429. doi: 10.7759/cureus.60429. eCollection 2024 May.
7
Ototoxicity: a high risk to auditory function that needs to be monitored in drug development.耳毒性:对听觉功能有高风险,在药物研发中需要进行监测。
Front Mol Neurosci. 2024 May 2;17:1379743. doi: 10.3389/fnmol.2024.1379743. eCollection 2024.
8
Phosphodiesterase type 5 inhibitors related hearing impairment: a real world study based on the FDA adverse event reporting system.磷酸二酯酶 5 抑制剂相关听力损伤:基于 FDA 不良事件报告系统的真实世界研究。
Sci Rep. 2024 Apr 28;14(1):9743. doi: 10.1038/s41598-024-60493-w.
9
Tinnitus: Clinical Insights in Its Pathophysiology-A Perspective.耳鸣:病理生理学的临床见解——一种观点。
J Assoc Res Otolaryngol. 2024 Jun;25(3):249-258. doi: 10.1007/s10162-024-00939-0. Epub 2024 Mar 26.
10
South African adolescents' lived experiences of acquired hearing loss following multidrug-resistant tuberculosis treatment.南非青少年在接受耐多药结核病治疗后获得性听力损失的生活经历。
Front Rehabil Sci. 2024 Feb 26;5:1336346. doi: 10.3389/fresc.2024.1336346. eCollection 2024.